TY - JOUR
T1 - Radiotherapy for unresectable sinonasal cancers
T2 - Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy
AU - Orlandi, Ester
AU - Giandini, Tommaso
AU - Iannacone, Eva
AU - De Ponti, Elena
AU - Carrara, Mauro
AU - Mongioj, Valeria
AU - Stucchi, Claudio
AU - Tana, Silvia
AU - Bossi, Paolo
AU - Licitra, Lisa
AU - Fallai, Carlo
AU - Pignoli, Emanuele
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background and purpose To compare volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) plans for treatment of unresectable paranasal sinuses cancers (PNSCs) with different clinical presentations. Material and methods Four patients treated for primary target volume only (group 1), four requiring elective nodal irradiation (group 2) and four with positive nodes in macroscopic disease (group 3) were selected. For each patient were generated 7 fields IMRT, coplanar VMAT (c-VMAT) and non-coplanar VMAT (nc-VMAT) treatment plans. Total doses were 70 Gy and 54 Gy to high dose planning target volume (HD-PTV) and low-dose-PTV, respectively. Dose-volume histogram, conformity and homogeneity index (CI and HI), and monitor units (MUs) per Gy were evaluated. Results VMAT provided significantly better target coverage, in terms of V100% (Volume encompassed by the isodose 100%), than IMRT, in particular when nc-VMAT was used. In general, organ at risk sparing is similar with the three approaches, although nc-VMAT can allow a statistically significant reduction of dose to contralateral parotid gland and cochlea for all three groups. Conclusions VMAT can offer significant improvement of treatment for all unresectable PNSCs over existing IMRT techniques. In particular, nc-VMAT may be a further advantage for those patients with sinonasal cancers and involvement of the nodes in whom large volumes and complex/irregular shape have to be irradiated, even if clinical benefits should be established in the future.
AB - Background and purpose To compare volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) plans for treatment of unresectable paranasal sinuses cancers (PNSCs) with different clinical presentations. Material and methods Four patients treated for primary target volume only (group 1), four requiring elective nodal irradiation (group 2) and four with positive nodes in macroscopic disease (group 3) were selected. For each patient were generated 7 fields IMRT, coplanar VMAT (c-VMAT) and non-coplanar VMAT (nc-VMAT) treatment plans. Total doses were 70 Gy and 54 Gy to high dose planning target volume (HD-PTV) and low-dose-PTV, respectively. Dose-volume histogram, conformity and homogeneity index (CI and HI), and monitor units (MUs) per Gy were evaluated. Results VMAT provided significantly better target coverage, in terms of V100% (Volume encompassed by the isodose 100%), than IMRT, in particular when nc-VMAT was used. In general, organ at risk sparing is similar with the three approaches, although nc-VMAT can allow a statistically significant reduction of dose to contralateral parotid gland and cochlea for all three groups. Conclusions VMAT can offer significant improvement of treatment for all unresectable PNSCs over existing IMRT techniques. In particular, nc-VMAT may be a further advantage for those patients with sinonasal cancers and involvement of the nodes in whom large volumes and complex/irregular shape have to be irradiated, even if clinical benefits should be established in the future.
KW - Dosimetric comparison
KW - Intensity modulated radiation therapy
KW - Normal tissue sparing
KW - Target coverage
KW - Unresectable paranasal sinus cancer
KW - Volumetric modulated arc therapy
UR - http://www.scopus.com/inward/record.url?scp=84916228489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84916228489&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2014.11.024
DO - 10.1016/j.radonc.2014.11.024
M3 - Article
C2 - 25467003
AN - SCOPUS:84916228489
SN - 0167-8140
VL - 113
SP - 260
EP - 266
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 2
ER -